Published in Cancer Weekly, February 6th, 2001
The significance of this finding could potentially be important to those working to develop new peptide based therapies for hepatocellular carcinoma (HCC), according to authors of the new study.
While working with the liver tissues of 45 patients with HCC, 16 patients with liver cirrhosis, and 12 with no liver disease, H.S. Chen et al. observed that MAGE-1 mRNA was present within the tumors of 32 patients with HCC. ...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2001-02-06)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.